Special Issue "Tumor Angiogenesis: An Update"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (15 March 2018)
Since the approval of the first anti-angiogenesis drug, Avastin, for treatment of colon cancer in 2004, efficacy limitations of this class of anticancer drugs have generated questions and doubts on the effectiveness of the anti-angiogenesis approach for anticancer treatment. Recent discoveries in the biology of tumor angiogenesis indicate that many new factors and regulators are involved in the regulation of tumor angiogenesis such as the immune system, microRNA, ion channel, autophagy, etc. This Special Issue will focus on new discoveries in the biology and drug targeting of tumor angiogenesis. Both review and research articles are welcome.
We look forward to receiving your contributions.Dr. Ruowen Ge
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.